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Abstract We have previously described the marine toxin 
okadaic acid (OKA) to be a potent neurotoxin for cultured rat 
cerebeHar neurons. Here we show that OKA-induced neurode- 
generation involves the DNA fragmentation characteristic of 
apoptosis and is protein synthesis-dependent. DNA fragmenta- 
tion and neurotoxicity correlated with inhibition of protein 
phosphatase (PP) 2A rather than PP1 activity. Neurotrophins 
NT-3 and BDNF failed to protect from OKA-induced apoptotic 
neurotoxicity that was, however, totally prevented by insulin-like 
growth factor-1. Neuronal death by OKA was significantly 
reduced by protein kinase C inhibitors and by the L-type calcium 
channel agonist Bay K8644, while it was potentiated by the 
reduction of free extracellular calcium concentrations. 
Key words: Okadaic acid; Neurotoxicity; Cerebellar neuron; 
Calcium channel; Protein kinase C; Phosphorylation 
1. Introduction 
Programmed neuronal cell death appears to result from a 
cascade of molecular and cellular events that occur at a spe- 
cific stage of differentiation a d may allow for the removal of 
excess neurons and the establishment of correct synaptic on- 
nections [1,2]. Despite the rapid progress that has taken place 
in the last year or two in the apoptosis field, the biochemical 
and molecular mechanisms underlying neuronal apoptosis are 
not yet very well defined. Several agents have been demon- 
strated to interfere with the apoptotic process in different 
neuronal cultures. Thus, cAMP and high KC1 block apoptosis 
in NGF-deprived sympathetic neurons [3], while brain-derived 
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and 
neurotrophin-4/5 (NT-4/5) all prevented apoptotic death in 
cultured cortical neurons following serum deprivation or ex- 
posure to the calcium channel antagonist nimodipine [4]. Cer- 
ebellar granule neurons in primary culture have recently been 
identified as a very convenient model to study central nervous 
system neuronal apoptosis in vitro [5]. Most of these neurons 
undergo apoptosis in culture unless they are grown in the 
presence of depolarizing conditions [5]. Naturally occurring 
DNA fragmentation has also been found in the granular layer 
of newborn rat cerebellum [6], suggesting the existence of an 
in vivo correlate of the apoptosis observed for neurons in 
culture. In cultured cerebellar granule neurons, apoptotic 
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death triggered by lowering extracellular KC1 concentration 
is associated with an immediate and permanent decrease in 
the levels of free intracellular calcium, [Ca2+]i, and could be 
inhibited by insulin-like growth factor 1 (IGF-1), by the 
cAMP-elevating agent forskolin and by cAMP analogues 
[5,7]. Interestingly, the signalling pathways by which these 
agents rescue neurons from apoptosis does not involve long- 
term modifications of [Ca2+]i, suggesting that the ability of 
IGF-1 and forskolin to prevent low K+-induced apoptosis 
may come from a common phosphorylation pathway that 
does not involve [Ca2+]i increase. 
Although a possible relationship between apoptosis and 
protein phosphorylation has been suggested in some tumour 
cell lines [8-10], there is no direct evidence for a role of pro- 
tein kinases and/or protein phosphatases in neuronal apopto- 
sis. We have previously reported that exposure of cultured 
cerebellar granule neurons to very low concentrations (0.5-5 
nM) of the protein phosphatase (PP) 1 and 2A inhibitor oka- 
daic acid (OKA) [11,12], results in widespread neurotoxicity 
[13,14]. Here we have investigated the role of protein phos- 
phorylation in apoptotic neurodegeneration of cultured cere- 
bellar granule neurons, and found that apoptosis can be trig- 
gered by inhibiting protein phosphatases, and in particular 
PP2A. Our results also suggest he involvement of protein 
kinase C (PKC) in this apoptotic process. The ability of in- 
tracellular calcium, IGF-1 and neurotrophins to prevent 
OKA-induced apoptosis has also been investigated. 
2. Materials and methods 
2.1. Cell culture 
Primary cultures of rat cerebellar g anule neurons were prepared as 
described previously [15]. Briefly, cerebella from 8-day-old pups were 
dissected, cells were dissociated and suspended in basal Eagle's medi- 
um (BME, Gibco) supplemented with 25 mM KCI, 2 mM glutamine, 
100 gg/ml gentamycin and 10% fetal calf serum. Cells were seeded in 
poly(L-lysine)-coated (5 gg/ml) dishes (NUNC) at 2.5× 105 cells/cm 2 
and incubated at 37°C in a 5% CO2, 95% humidity, atmosphere. 
Cytosine arabinoside (10 gM) was added after 20-24 h of culture to 
prevent proliferation of non-neuronal cells. After 8 days in vitro, 
morphologically identifiable granule cells accounted for more than 
95°/0 of the neuronal population, the remaining 5°/0 being essentially 
GABAergic neurons and astrocytes did not exceed 3% of the overall 
number of cells in culture [16]. Cerebellar granule neurons were kept 
alive for more than 40 days in culture, by replenishing the growth 
medium with glucose very 4 days and compensating forlost amounts 
of water, due to evaporation. 
2.2. Neuronal treatment and survival 
Neurons were used between 10 and 25 days in culture. Drugs were 
added in the growth medium for the indicated times. Then, growth 
medium was removed and cultures were incubated for 5 min with 1 ml 
incubation buffer containing 154 mM NaC1, 5.6 mM glucose, 8.6 mM 
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HEPES, 1 mM MgC12, 2.3 mM CaCl2, pH 7.4, to which the vital 
stain fluorescein diacetate (5 gg/ml) was added. The staining mixture 
wa~ then aspirated, replaced with incubation buffer, and cultures were 
examined for neurotoxicity. Under fluorescent light, live neurons 
showed a bright green colour in the cell body and neurites, while 
dead neurons did not retain any fluorescein diacetate, and their nuclei 
could be stained red by 1 rnin exposure to 50 I.tg/ml ethidium bromide. 
Ph~ ~tographs of three randomly selected culture fields were taken, and 
liw and dead neurons were counted. Total number of neurons per 
disl was calculated considering the ratio between the area of the dish 
an, the area of the picture (~ 2000). 
2.) Data presentation a d analysis 
"he mean+ S.D. of the data is reported. For statistical analysis 
on,.-way or two-way analysis of variance (ANOVA) was used to 
idt atify overall treatment effects. The unpaired two-tailed Student's 
t-t~ st was used for selective comparison of individual data groups. 
Ov ly significances relevant for the discussion of the data are indicated 
in ,'ach figure. 
2., DNA fragmentation a alysis 
qoluble DNA was extracted as described [17] and subjected to elec- 
tr~ phoresis in a 1.5% agarose gel. After treatment with RNAse A (20 
p~ ml for 3 h at 37°C), the gel was visualized by ethidium bromide 
straining. DNA molecular size (b) markers were included for compar- 
is~ a. 
2.. Materials 
~,ecombinant human IGF-I was from Boehringer Mannheim. Ca- 
lyL ulin A was from Moana Bioproducts Inc. (Honolulu, Hawai). Tau- 
to'.nycin was a generous gift from Dr. K. Isono (Riken, Wako, Sai- 
ta~na, Japan). Okadaic acid and okadaic acid methyl ester tetramethyl 
et!er were kindly provided by Dr. H. Fujiki (Saitama Cancer Center, 
lnt, Saitama, Japan). MK801 and nifedipine were a generous gift 
fr, m Dr. G.J. Kaczarowski (Merck Sharp and Dohme Laboratories, 
N ,  USA). NT-3 and BDNF were from Alomone Labs (Jerusalem, 
Is~ ael). (+)Bay K8644 was from Research Biochemicals International 
(/~.atick, MA, USA. GF 109203X was from Boehringer Mannheim. 
A other chemicals were from Sigma. 
3. Results 
3. P. Okadaic acid induces neuronal gene expression-dependent 
apoptosis 
Consistent with previous data [13,14], exposure of cultured 
ccrebellar granule neurons to 5 nM OKA resulted in wide- 
slread neurotoxicity over 24 h, decreasing the number of live 
murons from 850 + 100 x 10 z (n = 6) to 200 + 60 x 103 (n = 5) 
(! ig. 1C,F). Under fluorescent light, neurons treated with 5 
n!d OKA for 24 h and then stained with fluorescein diacetate 
(s ~e Section 2) showed considerable disintegration of neurites 
a~d swelling of cell bodies as compared to OKA-untreated 
clJtures (Fig. 1A,C). The presenee of vacuoles and cellular 
fi tgmentation was also evident. Neurotoxicity by OKA was 
a long-term process ince neither cell death nor morphological 
signs of toxicity were observed in neurons which had been 
e, posed to 5 nM OKA for 18 h (Fig. 1B,E) (860_+87×103 
n ~urons (n = 5)). 
The morphological changes accompanying OKA-induced 
n,,'urotoxicity resembled those reported for cells undergoing 
a'.~optosis [1,18]. To verify that death induced by OKA in 
c, rebellar neurons was due to apoptosis, we examined the 
ENA of these cells. As shown in Fig. 1E, agarose gel electro- 
p ~oresis of soluble DNA extracted from neurons treated with 
5 nM OKA for 18 h revealed considerable DNA fragmenta- 
tJ ~n characteristic of apoptotic cells, resulting from cleavage 
o "nuclear DNA in internucleosomal regions [19]. Fragmenta- 
t~ 3n of DNA was a very early event in the death process for it 
as already evident in DNA extracted from neurons which 
had been exposed to 5 nM OKA for only 9 h, while at least 24 
h were necessary to observe clear morphological signs of toxi- 
city and a significant decrease in neuronal survival (Fig. 
1C,E). Based on the intensity of ethidium bromide staining, 
DNA from 9-h-treated neurons showed quantitatively ower 
fragmentation than DNA from 18-h-treated neurons, whereas 
no soluble fragmented DNA was obtained from control neu- 
rons (Fig. IF). 
We examined whether OKA-induced apoptotic pathways 
required RNA synthesis by using the transcriptional inhibitor 
actinomycin D. We found that the presence of actinomycin D
(1 pg/ml) totally abrogated the neurotoxic effects of OKA 
(Fig. 1D,E) (770+93×103 neurons (n=4)), suggesting that 
newly synthesized protein(s) are necessary for OKA-mediated 
neurotoxicity. 
3.2. Role of PP1 and PP2A inhibition on apoptotic 
neurotoxicity by OKA. 
The low concentration of OKA (5 nM) we used here as well 
as in previous work [13,14] suggested that PP2A rather than 
PPI inhibition was responsible for the apoptotic degeneration 
induced by OKA. To determine further the specific role of 
PP1 and PP2A in inducing neuronal apoptotic death we 
used calyculin A and tautomycin, two potent PPs inhibitors 
with higher affinity for PP1 as compared to OKA. Thus, ca- 
lyculin A inhibits both enzymes with similar ICs0 [20], whereas 
tautomycin inhibits PP1 with approx. 10-fold greater affinity 
than PP2A [21]. As shown in Fig. 2A, concentrations above 
1 nM OKA and 5 nM calyculin A caused a concentration- 
dependent reduction in neuronal survival after 24 h. In con- 
trast, as much as 1 pM tautomycin was necessary to induce 
significant neurotoxicity. The concentrations producing half- 
maximal reduction in neuronal survival were 3.5 and 10 nM 
for OKA and calyculin A, respectively. When OKA was re- 
placed by okadaic acid methyl ester tetramethyl ether (OKA- 
TME), a derivative lacking PP inhibitory activity [22], no re- 
duction in neuronal survival was observed up to 1 pM OKA- 
TME (Fig. 2A). 
In agreement with these observations, exposure of neurons 
to calyculin A (25 nM, 19 h) but not to tautomycin or OKA- 
TME (both at 100 nM for 48 h), induced fragmentation of 
soluble DNA characteristic of apoptotic cells (Fig. 2B), 
further suggesting a role for protein phosphorylation due to 
PP2A inhibition in the apoptotic death induced by OKA and 
calyculin A. 
3.3. OKA-induced apoptotic neurotoxicity isprevented by 
IGF-1 but not by neurotrophins 
Neurotrophins have been documented to attenuate neuro- 
nal apoptotic death induced by different stimuli ncluding dep- 
rivation of serum or lowering of [Ca2+]i [4,23]. We checked 
the ability of cerebellar granule neurons to respond to NT-3 
and BDNF by testing whether these neurotrophins could pre- 
vent toxicity induced by exposure of neurons to dihydropyr- 
idine calcium channel antagonists. This treatment has been 
demonstrated to induce neurodegeneration in cultured cere- 
bellar granule neurons [24] possibly via apoptosis [7] as it has 
been reported for other neuronal cultures [4]. Addition of 
1 pM nifedipine (NIF) to the culture medium resulted in neu- 
ronal degeneration evolving slowly over 72 h, and reduced the 
number of surviving cells from 800 + 62 x 103 to 251 + 71 x 103 
neurons (n = 3). Pretreatment of neurons for 24 h with NT-3 
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Fig. 1. Okadaic acid induces neuronal gene expression-dependent apoptosis. Fluorescence photomicrographs of neuronal cerebellar cultures be- 
fore (A) and after 18 h (B) or 24 h (C) exposure to 5 nM okadaic acid (OKA). Live neurons howed a bright green color in the cell body and 
the neurites (large arrows), while nuclei of dead neurons appeared stained in red (small arrows). Addition of the transcriptional inhibitor acti- 
nomycin D (1 ~tg/ml) prevented neuronal degeneration and death (D). (E) Number of live neurons per dish (mean _+ S.D., n =4-6), before (con- 
trol) or after exposure to OKA for the indicated times. Neuronal survival after 24 h treatment with OKA (5 riM) in the presence of actinomy- 
cin D (1 ~tg/ml) is also represented (OKA+AcD). *P<0.01 vs control, and *P<0.0! vs OKA (24 h). (F) Agarose gel electrophoresis of
cerebellar neurons oluble DNA reveals a ladder pattern after 18 h exposure to 5 nM OKA (lane 1). Slight DNA fragmentation is also evident 
in neurons treated with 5 nM OKA for 9 h (lane 2), but not in control neurons (lane 3). 
or BDNF (both at 20 ng/ml) reduced the incidence of this cell 
death by 50% (NIF + NT-3 = 540-+ 65 × 103 neurons; N IF  + 
BDNF = 514 -+ 37 ×10 z neurons (n=3);  P<0.01  vs N IF  
alone). 
We therefore investigated the effect of NT-3 and BDNF on 
OKA-induced apoptotic neurotoxicity. We also examined 
IGF-1, which has been previously reported to prevent apop- 
tosis by low K + in cultured granule neurons [7]. As shown in 
Fig. 3A, pretreatment of neurons with 2.5 nM IGF-1 for 24 h 
prior to OKA addition, significantly increased the number of 
surviving neurons from 145+110×103 (n=6) to 750_+ 
150× 103 (n=6). In contrast, neither NT-3 nor BDNF (both 
at 20 ng/ml, up to 72 h) showed any protective ffect, and 
typical neurite disintegration (not shown) and cell death (Fig. 
3A) were observed after 24 h exposure to OKA in neurons 
pretreated with each neurotrophin [NT-3 = 200 _+ 50 × 103 neu- 
rons (n=6);  BDNF=60+22× 103 neurons (n=6)]. 
Consistent with these observations, preincubation of neu- 
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Fit.. 2. Induction of apoptotic neurotoxicity by protein phosphatase inhibitors with high affinity for PP2A. (A) Number of live neurons per 
disJl (mean + S.D., n = 4) after treatment of cultures for 24 h with OKA ((>) or calyculin A (O), or for 48 h with tautomycin (• )  or okadaic 
acid methyl ester tetramethyl ether (OKA-TME) (I), at the indicated concentrations. (B) Soluble DNA agarose gel electrophoresis reveals con- 
sid~'rable DNA fragmentation i  neurons exposed for 18 h to 25 nM calyculin A (lane 1) but not in neurons treated with 100 nM tautomycin 
(ladle 2), 100 nM OKA-TME (lane 3), or in control neurons (lane 4). 
ro~ls with 2.5 nM IGF-1 for 24 h totally prevented DNA 
fragmentat ion induced by OKA, while similar treatments 
w ih  20 ng/ml NT-3 and BDNF had no effect (Fig. 3B). 
3.~. Neurotoxicity by OKA is attenuated by calcium channel 
agonists 
Fo investigate the involvement of Ca 2+ in the apoptosis 
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induced by OKA, we examined the dependence of OKA neu- 
rotoxicity upon [Ca2+]i. We found that by adding the L-type 
Ca 2-- channel agonist Bay K8644 (1 p.M) to the culture me- 
dium 24 h prior to OKA, neuronal survival following 24 h 
exposure to 5 nM OKA significantly increased from 
300 + 47 X l0 s to 743 + 56 X l0 s neurons (n = 10) (Fig. 4). The 
non-competit ive NMDA-receptor  antagonist MK801 (1 ~tM) 
B 
Fi;. 3. Inhibition of OKA-induced apoptotic neurotoxicity by IGF-1 but not by neurotrophins. (A) Number of surviving neurons (mean + S.D., 
n = 6) before or after exposure of cerebellar neurons to 5 nM OKA without or with 24 h pretreatment with IGF-1 (2.5 nM), NT3 or BDNF 
(both at 20 ng/ml), respectively. *P< 0,01 vs control, and ~rp < 0.01 vs. OKA. (B) Agarose gel electrophoresis of soluble DNA shows extensive 
DNA fragmentation i  neurons pretreated for 24 h with 20 ng/ml NT3 (lane 1) or BDNF (lane 2) and then 5 nM OKA for 18 h. No DNA 
fragmentation is observed in neurons pretreated for 24 h with 2.5 nM IGF-1 prior to 18 h exposure to 5 nM OKA (lane 3) or in control neu- 
rons (lane 4). 
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was also added in these experiments in order to prevent ox- 
icity by excitatory amino acids endogenously released into the 
culture medium from Bay K8644-treated neurons [25]. Ca 2+- 
mediated protection was not permanent and no significant 
differences in neuronal survival were found between Bay 
K8644-treated and untreated neurons after 48 h exposure to 
5 nM OKA (data not shown). The role of extracellular Ca 2+ 
influx in attenuating the neurotoxic effects of OKA was 
further confirmed by using the membrane-impermeable Ca 2+
chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic 
acid (BAPTA). Reduction of free extracellular Ca 2+ concen- 
trations due to preincubation f neurons with 1 mM BAPTA 
for 24 h reduced the number of surviving neurons after 24 h 
exposure to OKA by 50% (Fig. 4), and the time of exposure 
to OKA required to induce neuronal death, which was at least 
6 h shorter in BAPTA-pretreated neurons compared to OKA 
alone. No significant differences in neuronal survival were 
observed in cultures treated with Bay K8644+MK801 
(950+75×103 neurons (n=10)) or BAPTA (780+85×103 
neurons (n = 10)) in the absence of OKA, compared to un- 
treated cultures (860 + 60 × 103 neurons (n = 10)). 
3.5. Role of  protein kinase A and prote& kinase C activity in 
OKA-induced neurotoxicity 
To investigate whether OKA affected the function of pro- 
teins phosphorylated by protein kinase A or protein kinase C 
(PKC), we first examined the effects of forskolin and phorbol 
esters on neuronal survival. Neither addition of I0 pM for- 
skolin, capable of increasing intracellular cAMP concentra- 
tion from 26 + 2 to 2760 + 275 pmol/mg protein, nor activa- 
tion of PKC by PMA (10-100 nM), resulted in significant 
reduction of neuronal survival after 24 h, compared to un- 
treated neurons (Table 1). No differences in the final number 
of surviving neurons or in the time of exposure to OKA 
needed to induce toxicity were observed when forskolin was 
added to the neurons imultaneously with OKA. However, 
when 10-100 nM PMA was co-added with OKA, neurotox- 
icity was totally prevented (Table 1). Given the prolonged 
treatments (24 h) needed in these experiments, we considered 
the possibility that down-regulation rather than activation of 
PKC activity could be responsible for the protection observed. 
For this purpose we used 5-isoquinolinylsulphonyl-2-methyl- 
piperazine (H7), an inhibitor of PKC and several other pro- 
tein kinases, and bisindolylmaleimide (GF 109203X), a potent 
Table 1 
Role of protein kinase A and protein kinase C activity in OKA-in- 
duced neurotoxicity 
Treatment Live neurons (X 10 -3) 
None OKA 
None 950 + 100 279 + 65 a 
Forskolin 870 + 120 350 + 39 
PMA 800 + 200 850 + 70 b 
H7 980+ 90 880+150 b 
GF108203X 900+ 90 894- + 60 b 
The number of live cells was determined as described in Section 2. 
Results are the mean + S.D. for triplicate cultures. Neurons were ex- 
posed to 5 nM okadaic acid (OKA) for 24 h. Forskolin (10 IxM) was 
added 10 min before OKA. H7 (50-100 /,tM) and GF108203X were 
added 1 h prior to OKA. PMA (10 100 nM) was added simulta- 
neously with OKA. 
~P < 0.01 vs None in the same line. 
bp< 0.01 VS OKA in the same column. 
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Fig. 4. Involvement of calcium in OKA-induced neurotoxicity. Neu- 
rons were exposed to 5 nM OKA for 15-18 or 24 h as indicated, in 
the absence or presence of Bay K8644 (1 /aM) or BAPTA (1 mM). 
Control represents untreated cultures. Results represent the number 
of surviving neurons (mean+ S.D., n = 10). *P< 0.01 vs OKA in 
the same group. 
and selective inhibitor of PKC activity [26]. As shown in Ta- 
ble 1, preincubation of neurons for 1 h with 50 ~tM H7 or 9 
~tM GF 109203X prevented neurotoxicity by 24 h exposure to 
5 nM OKA, suggesting the involvement of PKC in the phos- 
phorylation of substrates affected by OKA and leading to 
apoptotic death. 
4. Discussion 
Cultures exposed for at least 24 h to low concentrations of 
the PP1 and PP2A inhibitor OKA presented swollen cell 
bodies and extensive disintegration of the neurites, as well 
as a large number of vacuoles as a result of cellular fragmen- 
tation (Fig. 1C). Most of these features have been previously 
reported in neurons undergoing apoptosis [5]. Indeed, when 
DNA extracted from neurons exposed to OKA for at least 9 h 
was run on an agarose gel, it appeared as a ladder-like series 
of bands (Fig. IF), a hallmark of apoptosis [18]. It is worth 
noting that DNA fragmentation was detectable long before 
neuronal degeneration a d death could be observed, support- 
ing the idea that it is an early event in the death process. Our 
observation that OKA-induced apoptosis can be inhibited by 
inhibitors of RNA and protein synthesis indicates that apop- 
tosis by OKA is a genetically controlled process. Interestingly, 
the later two characteristics have also been described for low 
K+-induced apoptosis in cerebellar granule neurons [5], sug- 
gesting possible common targets in the pathway triggered by 
membrane hyperpolarization r by OKA. 
The fact that both OKA and calyculin A were effective in 
inducing neuronal apoptosis trengthens the evidence that it is 
a cellular process controlled by phosphorylation. Moreover, a 
closely related structural analog of OKA that is inactive to- 
ward phosphatases failed to induce apoptosis (Fig. 2). 
Although the specificities of the three PP inhibitors may be 
different in vivo, our results very much suggest that inhibition 
of PP2A rather than PP1 activity has a major contribution i
the induction of apoptosis by OKA and calyculin A. Thus, at 
the concentration we used (5 nM), OKA is likely to affect 
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mainly PP2A and not PP1, since OKA at concentrations a  
low as 1 nM has been shown to inhibit totally PP2A activity 
in x itro, whereas complete inhibition of PP1 activity needs at 
least 500 nM OKA [12,20]. Moreover, no DNA fragmentation 
or cell death (Fig. 2) was observed in cells treated with 100 
nM tautomycin, conditions under which the activity of native 
PP1 but not of PP2A should be completely inhibited [21]. 
Co~centrations of inhibitors producing neurotoxicity were 
usually 5-10-times higher than those reported for the inhibi- 
tio~ of catalytic activity in in vitro assays. In this respect, it 
sheald be considered that the catalytic subunits of PP1 and 
PP'~IIA are complexed to regulatory and/or targetting subunits 
in ivo [27], and therefore inhibition of native PPs may re- 
qui e higher concentrations of inhibitors than the free catalyt- 
ic sabunits [21,28]. Although a relative cell impermeability o
an~ of the PP inhibitors we used cannot be ruled out com- 
plelely, their lipophilic structures renders this possibility un- 
like ly. 
~'~ general protective ffect of neurotrophins against neuro- 
nal apoptosis has been previously suggested by Koh and co- 
wo kers who found NT-3, BDNF and NT-4/5 to be effective 
in protecting murine cortical neurons against apoptotic degen- 
era ion induced by Ca 2÷ channel antagonists and serum dep- 
riw,tion [4]. In cerebellar granule neurons, however, only a 
sm,dl but statistically significant effect has been found for 
Nq-3 in promoting survival of neurons maintained in low 
K ~ . while the protecting role of BDNF remained controver- 
siai [5,23]. The inability exhibited by NT-3 and BDNF to 
pr( tect neurons against apoptosis induced by OKA suggests 
that the protective ffect of neurotrophins may be restricted to 
ap,,ptosis elicited by stimuli inducing a decrease in [Ca2+]i. In 
fac , no differences in [Ca2+]i were observed using confocal 
las,'r microscopy in neurons exposed to OKA for 24 h (data 
no  shown). Alternatively, neurotrophins may be interfering 
up-tream with the signalling events triggered by OKA. 
IGF-1 prevention of granule cell death by OKA further 
sut ports a role for IGF-1 as a crucial physiological neuro- 
treghic factor for cerebellar granule neuron survival and de- 
vel )pment. Several ines of evidence have contributed to this 
co~ cept. Thus, IGF-1 induces the expression of functionally 
acl ve glutamate receptors in these neurons, and neutraliza- 
tio i of serum IGF-1 by a specific antibody reduces neuronal 
sul rival by 30-40% [29]. Although cerebellar granule neurons 
do not produce IGF-1 at any stage of development, they do 
ex I ,ress the IGF-1 receptor both in vivo [30] and in vitro (data 
no shown). Moreover, IGF-1 inhibits low K+-induced gran- 
ule neuron apoptosis [3]. The role of IGF-1 in supporting 
gn nule cell survival and development could be particularly 
sig lificant in vivo. Apoptosis has been shown to be a mecha- 
nisn of physiological cell death of cerebellar granule neurons 
du "ing the first 2 weeks of postnatal development [6], when 
gn nule cells migrate from the external to the internal granule 
la~ er, crossing a monolayer of postmitotic Purkinje neurons 
wi~ h which the granule neurons make synapses. Since IGF-1 is 
syJ thesized and secreted by cerebellar Purkinje cells, especially 
duing early postnatal life [31,32], taking up the IGF-1 se- 
cnted by Purkinje cells may be a crucial step for selecting 
ceJ ebellar granule neurons that will successfully differentiate 
fr( m those that will undergo apoptotic degeneration. It is 
terapting to speculate that this effect of IGF-1 in vivo may 
im olve modulation of protein phosphatases, and in particular 
of PP2A activity or substrates. 
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The observation that neuronal pretreatment with the cal- 
cium agonist Bay K8644 attenuates apoptosis by OKA was 
not surprising in that [Ca2+]i has previously been associated 
with neuronal survival in several neuronal models including 
cerebellar granule cells [24,33-35]. Moreover, convincing data 
have been reported in the last few years suggesting that neu- 
rons may die by apoptosis when their [Ca2+]i levels decrease 
below a certain threshold in the absence of survival factors 
[7,36]. Ca2+-mediated protection from neuronal apoptosis 
probably results from a combination of modulatory effects 
of this ion on several intracellular targets, including protein 
kinases and phosphatases. PP1 as well as PP2A and most 
PP2A-type activities are independent of Ca 2+. However, ele- 
vated [Ca2+]~ levels are known to stimulate the activity of the 
Ca2+-dependent calmodulin-stimulated PP2B calcineurin [37], 
which in turn activates PP1 via the dephosphorylation f 
cAMP- and cGMP-regulated PP1 inhibitors (see [38] for a 
review). Mammalian PP1 and PP2A show 43% overall se- 
quence identity and have overlapping specificities in vitro 
[39]. It may therefore be possible that a larger fraction of 
PP1 molecules in the active form in Bay K8644-pretreated 
neurons could partially compensate the imbalance of the ki- 
nase/phosphatase system induced by OKA. The observation 
that Bay K8644 delayed rather than prevented neuronal death 
would be consistent with this possibility. Alternatively, calci- 
neurin may dephosphorylate substrates such as the microtu- 
bule-associated proteins MAP-2 and tau [38], of which the 
phosphorylation level may be particularly relevant for neuro- 
nal survival and function [40]. Indeed, severe disturbances in
the phosphorylation of microtubule associated proteins are 
known to accompany the neuronal cytoskeletal pathology 
characteristic of Alzheimer's disease brains [41-43]. Although 
more studies are needed to establish the nature of protein 
kinases responsible for the phosphorylation of substrates af- 
fected by OKA and leading to apoptotic death, the protecting 
effect observed for H7 and GF 109203X indicates that PKC 
may be involved. Interestingly, PKC activity has been re- 
ported to be altered in Alzheimer's disease brain [44,45] and 
both OKA and PKC activity-stimulating a ents led to an 
abnormal processing of Alzheimer [3/A4 amyloid precursor 
protein [46], further suggesting a key role for PP2A and 
PKC activities in maintaining the physiological phosphoryla- 
tion/dephosphorylation balance. 
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